“Misconceptions of Alternative Treatments for COVID and their Toxicological Consequences”
Event Navigation
HealthTrust presents…“Misconceptions of Alternative Treatments for COVID and their Toxicological Consequences”
Please Note: Continuing education credit is only available to those attending the session live. CE credit is not available when accessing the program on demand.
With the rise of COVID since December of 2019, there has been an associated increase in the inappropriate use of medications intended to treat the disease. Misinformation regarding potential COVID treatments has led to surges of toxicity with several agents, leading to moderate‐to‐severe poisonings/overdoses. Agents like hydroxychloroquine, ivermectin, and colchicine have been reported to be the cause of many toxicities since the beginning of the pandemic. The purpose of the presentation is to review the appropriate uses of these medications, define their place in COVID therapy and discuss the dangers of toxicity associated with each agent.
Learning Objectives for Pharmacists & Nurses | At the end of this session, participants should be able to:
- Recall the toxicological manifestations associated with the use of hydroxychloroquine, ivermectin and colchicine for the treatment of COVID.
- Recognize the guideline recommendations for the use of hydroxychloroquine, ivermectin and colchicine for use in the treatment and prevention of COVID.
- Identify counseling strategies for patients on the risks associated with off‐label COVID treatments.
Learning Objectives for Pharmacy Techs | At the end of this session, participants should be able to:
- Recognize agents commonly used in off‐label COVID treatment which put a patient at risk for toxic manifestations.
- Recall appropriate indications for hydroxychloroquine, ivermectin and colchicine.
- Identify counseling strategies for patients on the risks associated with off‐label COVID treatments.
Presenter:
Rhonda Abouelela, PharmD, RPh | PGY‐1 Pharmacy Resident | Atlantic Health System
Target Audience: Pharmacists, Pharmacy Techs & Nurses
Continuing Education Information: 1.0 contact hours approved for Pharmacists, Pharmacy Techs & Nurses. Belmont University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The ACPE Universal Activity Numbers for this activity are 0863-9999-22-035-L01-P and 0863-9999-22-035-L01-T. The activity is approved for 1 hour of continuing education credit for pharmacist, pharmacy techs and nurses who attend the webinar and complete the online evaluation. Pfiedler Education is a division of AORN, provider approved by the California Board of Registered Nursing, Provider Number CEP13019, for 1 contact hour. 1.0 contact hours approved for Nurses.
Note about CE credit: If you plan to obtain credit for a live session, stay until the end of the presentation to receive the verification code you will need to obtain the continuing education credit. CE credit is individual. No group credit is available. Each person must register for a webinar and attend the webinar in its entirety in order to receive an email after the event with instructions on how to apply for continuing education credit. Attendees should not share the code or forward the email to others who did not actually attend the program. If they are not able to be verified on our webinar provider reports and registration list they will not receive credit. If you are joining only by phone, you will not be eligible for credit. You must also log in and join the visual portion of the webinar to be part of our CE provider-required reporting.
